《新股》翰思艾泰(03378.HK)招股入场费3,232.27元 引7名基石投资者

阿斯达克财经
Dec 15, 2025

拥有结构生物学、转化医学及临床开发方面自主专业技术及经验的生物科技公司翰思艾泰-B(03378.HK)今日(15日)起招股,共发售1,832.1万股,当中香港公开发售183.21万股,每股招股价28至32元,以一手100股计,入场费3,232.27元,集资最多约5.9亿元,招股期至12月18日,预计本月23日挂牌。独家保荐人为工银国际融资。公司引入7名基石投资者,包括富德资源、Sage ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10